VFA
VIVS

Virtus Fund Advisers’s VivoSim Labs VIVS Stock Holding History

Virtus Fund Advisers’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-22
Closed -$45K – 1983
2014
Q2 		$45K Buy
+22
New +$36.9K ﹤0.01% 1945

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CNB
City National Bank Beverly Hills, California $11.6B AUM 3.11% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Virtus Fund Advisers's VIVS Position: Q3 2014 in Review

Virtus Fund Advisers sold out of VivoSim Labs (VIVS) in Q3 2014, closing a stake of 22 shares — an estimated $45K sold.

Virtus Fund Advisers first reported a position in VIVS in Q2 2014 and held it in 1 quarter. The position peaked at $45K in Q2 2014. 100 funds tracked by Wall St. Rank hold VIVS as of Q3 2014.

  • Virtus Fund Advisers reported no remaining VivoSim Labs position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 22 VivoSim Labs shares in Q3 2014, an estimated $45K.
  • Virtus Fund Advisers first reported a position in VivoSim Labs in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's VivoSim Labs position peaked at $45K in Q2 2014.
  • 100 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.